These analyses predicted that POLE expression promotes tumor progression and immune escape of ccRCC via regulation of combined inhibition by the Notch and JAK/STAT pathways as well as by PD-L1 expression (Supplementary Figure S3). The gene discussed is POLE; the disease is nonpapillary renal cell carcinoma.